Europe Diabetes Care Devices Market-Market Dynamics
In the European Union (EU), there are more than 31 million people living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population and is expected to reach around 10% by 2025. This signifies the increasing market of diabetes device in the EU. The report details several factors driving and restraining the market. Some of these are listed below. The major opportunities and challenges that the market players face are also discussed.
The European diabetes care devices market is driven by various factors like:
Increasing incidence of diabetes
Increased R&D activities in the diagnosis and treatment of diabetes,
Increase in obese people
Favorable government policies
The major factors restraining the market are:
High cost of diabetes devices
Lack of awareness about new diabetes care devices
Opportunities and Challenges
Development of new formulations and technologies for delivery of insulin, improved primary care structure and the demand for non-invasive diabetes diagnostic and drug delivery services are some of the market opportunities for the players. However, they face the challenge of dealing with stringent regulations and lack of expertise in diabetes management.
The European diabetes care device market is segmented based on its products into blood glucose monitoring device and insulin delivery devices. Based on glucose monitoring devices, the market is further segmented into continuous glucose monitors, self-monitoring blood glucose meters, infusion sets, testing strips, lancets and other glucose monitoring product. Based on insulin delivery devices, the market is segmented into insulin pumps, insulin syringes insulin jet injectors and insulin pens.
Based on geographical location, the European diabetes care devices market can be broadly divided into France, UK, Germany, Spain, Portugal, Scandinavia, and Italy.
Market analysis for the Europe diabetes care devices market, with region-specific assessments and competition analysis on a regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market.
Identification and analysis of the macro and micro factors that affect the Europe diabetes device care on a regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
1.1 Study deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and forecast period years
1.6 General Study Assumptions
2. RESEARCH METHODOLOGY
2.2 Analysis Methodology
2.3 Econometric forecast models
2.4 Research Assumptions
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current market scenario
5.2 Technology Overview
5.3 New developments in therapeutics
5.4 Investment analysis
5.5 Porters Five Force Analysis
5.5.1 Bargaining Power of suppliers
5.5.2 Bargaining power of buyers
5.5.3 Degree of competition
5.5.4 Threat of substitution
5.5.5 Threat of new entrants
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Increasing incidence of diabetes
6.1.2 Increased R&D activities in diagnosis and treatment of diabetes
6.1.3 Technological innovations
6.1.4 Increase in obese population
6.1.5 Favorable Government policies
6.2 Market Restraints
6.2.1 High cost of diabetes care devices
6.2.2 Reimbursement issues
6.2.3 Patent expiry
6.2.4 Lack of awareness about new diabetes care devices
6.3 Key Challenges
6.3.1 Stringent regulations
6.3.2 Lack of healthcare expertise in diabetes management
6.4 Market opportunities
6.4.1 Development of new formulations and technologies for delivery of insulin
6.4.2 Improved primary care structure
6.4.3 Non-invasive diabetes diagnostic and drug delivery devices
6.4.4 Europe Diabetes care market segmentation
220.127.116.11 Blood Glucose Monitoring Devices
18.104.22.168 Continuous glucose monitors
22.214.171.124 Self-monitoring Blood glucose meters
126.96.36.199 Infusion sets
188.8.131.52 Testing strips
6.4.5 Other Glucose products
184.108.40.206 Insulin Delivery Devices
220.127.116.11 Insulin pumps
18.104.22.168 Insulin Syringes
22.214.171.124 Insulin Jet Injectors
7. Insulin pens
8. Europe diabetes care devices market by Geography - Regional shares and forecast
8.5 Spain and Portugal
8.8 Rest of Europe
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.1 Becton, Dickinson, and Company
10.2 Johnson and Johnson
10.3 Abbott Laboratories
10.4 Acon Laboratories, Inc.
10.5 Medtronic PLC
10.6 Dexcom, Inc.
10.8 GlaxoSmithKline PLC
10.9 Roche Diagnostics
10.10 Novo Nordisk
10.11 Elli Lilly
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market